Patient Centric Approaches for Rare and Ultra-Rare Diseases with Lawrence Bressler, Head of Value & Market Access, Global Rare Diseases at Chiesi
Listen now
Description
Lawrence Bressler, Head of Value & Market Access, Global Rare Diseases at Chiesi, shares how Chiesi is revolutionizing the lives of people living with rare diseases on a global scale. He also discusses key ways for life science companies to engage with patient communities, the importance of pharmaceutical companies maintaining high social and environmental standards, current market access barriers, and more! To find out more about Impetus: https://www.meetwithimpetus.com Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/ Impetus Digital Website: https://www.impetusdigital.com/ Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/ Impetus Digital Twitter: https://twitter.com/impetus_digital Impetus YouTube: https://www.youtube.com/ImpetusDigital Lawrence Bressler: https://www.linkedin.com/in/lawrencebressler/ Chiesi: https://www.chiesiusa.com/
More Episodes
Dr. Joshua Liu, Co-founder & CEO of SeamlessMD, explores how technology and “Digital Care Journeys” can help hospitals reduce the surgical backlog for high-volume procedures like hip and knee replacements, the evolution of healthcare delivery, and more. Connect with Dr. Joshua...
Published 02/21/23
Published 02/21/23
Dr. Ittai Dayan, Co-founder & CEO of Rhino Health, shares how his company is transforming the way healthcare AI solutions are created, adopted and measured. He will also explore how to create equitable access to advanced AI-based diagnostics and treatment pathways, how biopharma companies can...
Published 01/25/23